Land: Nya Zeeland
Språk: engelska
Källa: Medsafe (Medicines Safety Authority)
Fluconazole 150mg;
JNTL Consumer Health (New Zealand) Limited
Fluconazole 150 mg
150 mg
Capsule
Active: Fluconazole 150mg Excipient: Colloidal silicon dioxide Gelatin Lactose monohydrate Magnesium stearate Maize starch Patent blue V TekPrint black SW-9008 Titanium dioxide
Blister pack, PVC/AL foil; single capsule pack, 1 capsule
Restricted
Restricted
Pfizer Pharmaceuticals LLC
Vaginal candidiasis.
Package - Contents - Shelf Life: Blister pack, PVC/AL foil; single capsule pack - 1 capsules - 60 months from date of manufacture stored at or below 30°C
2004-05-17
DIFLUCAN ® 1 DIFLUCAN ® _Fluconazole (flu-con-a-zole)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Diflucan. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Diflucan against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT DIFLUCAN IS USED FOR Diflucan capsules (for adults) and oral suspension (for children) are used to treat certain fungal and yeast infections. Diflucan belongs to a group of medicines called azole antibiotics. It works by preventing the growth of the fungal and yeast organisms causing your infection. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY DIFLUCAN HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed Diflucan for another reason. Diflucan is available only with a doctor's prescription. This medicine is not addictive. BEFORE YOU TAKE DIFLUCAN _WHEN YOU MUST NOT TAKE IT_ Do not take Diflucan if you have an allergy to: any medicine containing fluconazole medicines related to fluconazole such as miconazole, ketoconazole or clotrimazole any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. DIFLUCAN SHOULD NOT BE GIVEN IF YOU ARE TAKING CISAPRIDE (A MEDICINE USED TO TREAT STOMACH PROBLEMS). DO NOT TAKE THIS MEDICINE IF THE EXPIRY DATE (EXP) PRINTED ON THE PACKAGING HAS PASSED OR IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. If it has expired or is damaged, return it to your pharmacist for disposal. IF YOU Läs hela dokumentet
1 DIFLUCAN® ONE Data Sheet Date of preparation: 13 July 2022 NEW ZEALAND DATA SHEET 1 PRODUCT NAME DIFLUCAN ® ONE _Fluconazole Capsule 150 mg _ 2 QUALITATIVE AND QUANTITATIVE COMPOSITION DIFLUCAN ® ONE contains its active ingredient fluconazole 150 mg as capsule. DIFLUCAN ® ONE One also contains lactose and sugars For the full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM DIFLUCAN ® ONE capsule has a light turquoise blue opaque cap and body marked with FLU-150. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS DIFLUCAN ® ONE, given orally, is indicated for vaginal candidiasis. 4.2 DOSE AND METHOD OF ADMINISTRATION DIFLUCAN ® ONE is administered orally. Use in Adults For vaginal candidiasis, fluconazole 150 mg (DIFLUCAN ® ONE) should be administered as a single oral dose. The median time to onset of symptom relief following a 150 mg single oral dose for the treatment of vaginal candidiasis is one day. The range of time to onset of symptom relief is one hour to nine days. Use in Children Single dose fluconazole is not recommended for use in children under 18 years of age except under doctor supervision. Use in Renal Impairment Fluconazole is predominantly excreted in the urine as unchanged medicine. No adjustments in single-dose therapy are necessary in patients with minor to moderate renal impairment. 2 DIFLUCAN® ONE Data Sheet Date of preparation: 13 July 2022 4.3 CONTRAINDICATIONS Fluconazole should not be used in patients with known sensitivity to fluconazole; to related azole compounds; or to any of its excipients. Co-administration of other drugs known to prolong the QT interval and which are metabolised via the enzyme CYP3A4 such as cisapride, astemizole, erythromycin, pimozide and quinidine are contraindicated (see Section 4.4). Coadministration of terfenadine is contraindicated in patients receiving fluconazole at multiple doses of 400mg per day or higher based upon results of a multiple dose interaction study. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Fluconazole should be admini Läs hela dokumentet